BerGenBio ASA Valuation
| BRRGF Stock | USD 97.09 0.00 0.00% |
At this time, the firm appears to be fairly valued. BerGenBio ASA shows a prevailing Real Value of $99.03 per share. The current price of the firm is $97.09. Our model approximates the value of BerGenBio ASA from analyzing the firm fundamentals such as Shares Outstanding of 88.66 M, operating margin of (383.14) %, and Return On Equity of -0.96 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that BerGenBio ASA's price fluctuation is out of control at this time. Calculation of the real value of BerGenBio ASA is based on 3 months time horizon. Increasing BerGenBio ASA's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the BerGenBio pink sheet is determined by what a typical buyer is willing to pay for full or partial control of BerGenBio ASA. Since BerGenBio ASA is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BerGenBio Pink Sheet. However, BerGenBio ASA's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 97.09 | Real 99.03 | Hype 97.09 |
The real value of BerGenBio Pink Sheet, also known as its intrinsic value, is the underlying worth of BerGenBio ASA Company, which is reflected in its stock price. It is based on BerGenBio ASA's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of BerGenBio ASA's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of BerGenBio ASA helps investors to forecast how BerGenBio pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BerGenBio ASA more accurately as focusing exclusively on BerGenBio ASA's fundamentals will not take into account other important factors: About BerGenBio ASA Valuation
The pink sheet valuation mechanism determines BerGenBio ASA's current worth on a weekly basis. Our valuation model uses a comparative analysis of BerGenBio ASA. We calculate exposure to BerGenBio ASA's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BerGenBio ASA's related companies.BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in the developing drugs to treat immune evasive, drug resistant, and metastatic cancers. The company was incorporated in 2007 and is headquartered in Bergen, Norway. Bergenbio is traded on OTC Exchange in the United States.
8 Steps to conduct BerGenBio ASA's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates BerGenBio ASA's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct BerGenBio ASA's valuation analysis, follow these 8 steps:- Gather financial information: Obtain BerGenBio ASA's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine BerGenBio ASA's revenue streams: Identify BerGenBio ASA's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research BerGenBio ASA's industry and market trends, including the size of the market, growth rate, and competition.
- Establish BerGenBio ASA's growth potential: Evaluate BerGenBio ASA's management, business model, and growth potential.
- Determine BerGenBio ASA's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate BerGenBio ASA's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for BerGenBio Pink Sheet analysis
When running BerGenBio ASA's price analysis, check to measure BerGenBio ASA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BerGenBio ASA is operating at the current time. Most of BerGenBio ASA's value examination focuses on studying past and present price action to predict the probability of BerGenBio ASA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BerGenBio ASA's price. Additionally, you may evaluate how the addition of BerGenBio ASA to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |